How to Buy Biocryst Pharmaceuticals Stock
Biocryst Pharmaceuticals Inc
BioCryst Pharmaceuticals, Inc. , a biotechnology company, discovers novel, oral, and small-molecule medicines.
Biocryst Pharmaceuticals stock last closed at $7.91, down 1.98% from the previous day, and has increased 2.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.51 percentage points. Biocryst Pharmaceuticals stock is currently +31.5% from its 52-week low of $6.02, and -30.06% from its 52-week high of $11.31.
As of Sep 12, 2025, there are 209.92M shares of BCRX outstanding. The market value of BCRX is $1.66B. In the past 24 hours, 3.2M BCRX shares were traded.
How to Buy Biocryst Pharmaceuticals Stock
Wondering how to invest in Biocryst Pharmaceuticals stock? Here's how.
- Choose where to buy Biocryst Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you decide where to buy Biocryst Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Pick your payment method and add your information.
- Evaluate Biocryst Pharmaceuticals stock: The Biocryst Pharmaceuticals ticker symbol is BCRX. Is Biocryst Pharmaceuticals stock a good investment? Should you buy shares of BCRX? How do BCRX's underlying business fundamentals look? Do top analysts think Biocryst Pharmaceuticals is a good buy? Why has BCRX's stock price moved recently? (Hint: Our stock research website can help you decide if BCRX is a good stock to buy).
- Execute your BCRX purchase: Decide if you will purchase BCRX shares at the current market price or use a limit order to buy BCRX stock at a given price.
- Get updates on your BCRX investment: Create a watchlist to monitor your position in Biocryst Pharmaceuticals stock.
Step 1: Choose where to buy Biocryst Pharmaceuticals stock
You need a brokerage account to access the NASDAQ market and buy BCRX shares.
Our recommended brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the best brokerage, you need to fill out some personal information so you can buy BCRX today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create your new brokerage account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have finished signing up on mobile trading apps, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing money into your investment account.
Step 4: Evaluate Biocryst Pharmaceuticals stock
After you have selected the best place to buy Biocryst Pharmaceuticals stock, it's critical to research their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Biocryst Pharmaceuticals stock at a glance
Biocryst Pharmaceuticals Due Diligence Score
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BCRX's stock page.
What is the fair value of BCRX stock?
Investors use many financial metrics, analyses, models, and charts to gauge BCRX's true value.
You can access more valuation research on BCRX's stock here.
A quick look at BCRX Financials
Pros:
- BCRX profit margin has gone up from -38.2% to -6.4% in the past year.
- There are more short-term assets than short-term liabilities on the BCRX balance sheet.
Cons:
- BCRX debt to equity ratio of -2.08 is negative.
- BCRX's operating cash flow of $16.82M allows it to safely service it's debt of $738.92M.
- There are more long-term liabilities than short-term assets on the BCRX balance sheet.
- Total BCRX debt is still negative.
- BCRX earnings of $62.16M is not sufficient to cover its interest payments.
Is Biocryst Pharmaceuticals stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 8 sell side analysts who monitor BCRX, the consensus analyst rating on BCRX is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent BCRX Analyst Ratings
Jessica Fye, a top 4% analyst from JP Morgan maintains BCRX with a strong buy rating and raises their BCRX price target from $10.00 to $13.00, on May 6, 2025.
Andrew Fein, a top 1% analyst from HC Wainwright & Co. reiterates BCRX with a buy rating and maintains their BCRX price target from $30.00 to $30.00, on May 6, 2025.
Steven Seedhouse, a top 15% analyst from Cantor Fitzgerald initiates coverage on BCRX with a strong buy rating and announces their BCRX price target of $20.00, on Apr 29, 2025.
You can dig deeper into what analysts are saying on the Biocryst Pharmaceuticals stock forecast page.
BCRX Technical Indicators
BCRX Growth Metrics
Last year, BCRX revenue was $557.51M. In the past five year, BCRX's revenue has gone up by 62.51% per year. This was slower than the Biotechnology industry average of 66.52%.
You can analyze BCRX's earnings and revenue performance here.
What are BCRX executives and large shareholders up to?
Over the last year, insiders at BCRX have sold more shares than they have bought.
Steven Frank, Director of BCRX, was the latest BCRX insider to buy. They bought $11,243.43 worth of BCRX stock on Aug 29, 2025.
Dig into more about who owns BCRX stock here.
Can I rely on BCRX as an income stream?
No, Biocryst Pharmaceuticals doesn't provide an income stream by paying out dividends.
BCRX Social Trading Data
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your BCRX purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you need more info about buying stocks on eToro, click the helpful video below:
Step 6: Get updates on your BCRX investment
Now that you own some BCRX stock, you'll want to stay up-to-date on your new company.
Add BCRX to a watchlist to track the most important metrics related to your BCRX stock.
BCRX Feed
How to Buy Stock in Biocryst Pharmaceuticals
To reiterate, here are the 6 steps you need to take to buy Biocryst Pharmaceuticals stock right now:
- Choose where to buy Biocryst Pharmaceuticals stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Evaluate Biocryst Pharmaceuticals stock
- Execute your BCRX purchase
- Get updates on your BCRX investment
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to track your new investment in Biocryst Pharmaceuticals, add BCRX to your watchlist below.
Other Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.